Agenda

Our 2024 Innovations Conference was held on September 24, 2024.

Below is the agenda for the event.

 

 

I.  Welcome

Presented by:
Dr. Bozena Michniak-Kohn
Rutgers University, Ernest Mario School of Pharmacy
Center for Dermal Research, founder and Director

 

 

II. Plenary Speaker Sessions – sponsored by

 

“The 2024 Dermatology Market: The Good, The Bad and The Ugly”  Click here for abstract

Presented by:
Dr. Seth Orlow
New York University/Pharus Advisors

 

 

 

“Non-Surgical Skin Cancer Treatment using Bioadhesive Nanoparticles”  Click here for abstract

Presented by:

Dr. Michael Girardi, MD
Department of Dermatology, Yale School of Medicine

and

 

Dr. W. Mark Saltzman
Department of Biomedical Engineering, Yale University

 

 

 

III. Company Spotlight Sessions

Fount Bio presented by Dr. Doug Levinson

Learn more about Fount Bio here

 

Sol-Gel presented by Dr. Ofer Toledano

Learn more about Sol-Gel Technologies here

 

Naturalis presented by Dr. Raffaele Cece

Learn more about Naturalis

 

IV.  Intensive Parallel Tracks

Attendees may select which session to attend, all sessions will be available to attendees for 60 days post conference for viewing.

 

Track 1:  Skin Biology & the Science of Topicals

“Light-based Beauty Tech, the Next Frontier in Skin Rejuvenation”  Click here for abstract
presented by Dr. Lieve Declercq, Skin-DLite (bv) and Proya Cosmetics Co LTD

 

 

“Topical Drug R&D using Open-Flow Microperfusion: Insights into Skin Biology”  Click here for abstract
presented by Dr. Manfred Bodenlenz, JOANNEUM RESEARCH HEALTH- Institute for Biomedical Research and Technologies

 

 

“Spatial Distribution Assessment of Topically Applied Submicron Drug Precipitants on Cadaver Human Scalp”  Click here for abstract
presented by Dr. Jean-Philippe Therrien, JP Therrien Consulting LLC

 

 

“Solving Formulation Challenges: Solubility & Drug Targeting”    Click here for abstract
presented by Dr. Bozena Michniak-Kohn, Rutgers University, Center for Dermal Research and Ernest Mario School of Pharmacy

 

 

 

“Troubleshooting and Trouble Avoiding for Topical Semi-Solid Formulations”  Click here for abstract
presented by Dr. Michael Herbig, RaDes GmbH

 

 

“AI Image Analytics for Topicals: Implications for Drug Delivery and Q3 Microstructure Equivalence”  Click here for abstract
presented by Joshua Lomeo, Director of Application Science, digiM solution

 

Track 2: Dermatological & Cosmeceutical Product Development 

“Ground-breaking Digital Transformation in Topical Product Development” 
presented by Dr. Ravi Shekar Ananthula, PharmaDEM    Click here for abstract

 

 

“Fast Fun Excipient Selection with Formulating for Efficacy Software”  Click here for abstract
presented by Mark Chandler, President ACT Solutions

 

 

“Pre-formulation Strategies and Non-clinical Inputs:  Derisking Clinical Topical Formulation Selection”  Click here for abstract
presented by Dr, Kevin Warner, Tarsus Pharmaceuticals, Inc.

 

 

“Dermal PK in the Clinic: Using Streamlined Biopharmaceutics Practices for Product Evaluation”
presented by Dr. Audra Stinchcomb, University of Maryland

 

 

 

“Understanding the Microstructure of Semisolid Topical Products: Impact of Manufacturing and Formulation Parameters”  Click here for abstract
presented by Dr. Abu Badruddoza, Pfizer

 

“Bringing Topical Drugs to Patients’ Skin:  Managing the Drug Delivery Ecosystem”  Click here for abstract
presented by Dr. Stefan Hellbardt, Aptar

 

V.  Panel Discussion/Wrap Up Session

“Introduction of a Dermatology Drug Product to the Market and Evolving Post Launch into Commercialization:  An Industry Perspective”

 

Paul Seaback

Chief Technical Officer

Dermavant Sciences, Inc.

and

 

Leisha Martin

Global Head of Quality

Dermavant Sciences, Inc.

 

   Panel discussion to be moderated by Dr. Vijendra Nalamothu